Nuclear medicine UK: signs of progress

le Josef Ell, Peter
Foilsithe 2004

Radionuclides in Nephrology

le Ell, Peter Josef
Foilsithe 1983

What’s up in nuclear medicine?

le Ell, Peter J.
Foilsithe in Cancer Imaging (2015)

The contribution of medical physics to nuclear medicine: a physician's perspective

le Ell, Peter J
Foilsithe in EJNMMI Phys (2014)

Editorial

le Ell, Peter J
Foilsithe in Clin Med (Lond) (2006)

If I Were a Patient

le Ell, Peter Josef
Foilsithe in J R Coll Physicians Lond (1993)

Management of Myocardial Infarction

le Ell, Peter Josef
Foilsithe in J R Coll Physicians Lond (1994)

PET and SPECT in common neuropsychiatric disease

le Tatsch, Klaus, Ell, Peter J
Foilsithe in Clin Med (Lond) (2006)

Atlas of lymphoscintigraphy and sentinel node mapping a pictorial case-based approach /

le Mariani, Giuliano, Ell, Peter Josef, Lucignani, Giovanni
Foilsithe c201

18F-fluorodeoxyglucose PET/CT in cancer imaging

le Ell, Peter J, Kayani, Irfan, Groves, Ashley M
Foilsithe in Clin Med (Lond) (2006)

Emission Tomography in Embolic Lung Disease

le Donaldson, Robert M., Khan, Omar, Bennett, J. Graeme, Ell, Peter J.
Foilsithe 1982

Allergy to Technetium-Labelled Nanocolloidal Albumin for Sentinel Node Identification

le Chicken, Dennis W, Mansouri, Reza, Ell, Peter J, Keshtgar, Mohammed RS
Foilsithe 2007

The role of (18)FDG PET/CT in the management of colorectal liver metastases

le Engledow, Alec H, Skipworth, James RA, Pakzad, Farrokh, Imber, Charles, Ell, Peter J, Groves, Ashley M
Foilsithe 2012

Vasodilator myocardial perfusion imaging: demonstration of local electrophysiological changes of ischaemia

le John, Roy M, Taggart, Peter I, Sutton, Peter M, Costa, Durval C, Ell, Peter J, Swanton, Howard
Foilsithe 1992

Integrated (18)F-Fluorodeoxyglucose–Positron Emission Tomography/Dynamic Contrast-Enhanced Computed Tomography to Phenotype Non–Small Cell Lung Carcinoma

le Shastry, Manu, Miles, Kenneth A., Win, Thida, Janes, Sam M., Endozo, Raymond, Meagher, Marie, Ell, Peter J., Groves, Ashley M.
Foilsithe 2012

Exenatide and the treatment of patients with Parkinson’s disease

le Aviles-Olmos, Iciar, Dickson, John, Kefalopoulou, Zinovia, Djamshidian, Atbin, Ell, Peter, Soderlund, Therese, Whitton, Peter, Wyse, Richard, Isaacs, Tom, Lees, Andrew, Limousin, Patricia, Foltynie, Thomas
Foilsithe 2013

Defining the Role of PET–CT in Staging Early Breast Cancer

le Groves, Ashley M., Shastry, Manu, Ben-Haim, Simona, Kayani, Irfan, Malhotra, Anmol, Davidson, Timothy, Kelleher, Tina, Whittaker, Diane, Meagher, Marie, Holloway, Brian, Warren, Ruth M., Ell, Peter J., Keshtgar, Mohammed R.
Foilsithe 2012

Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients

le Win, Thida, Thomas, Benjamin A., Lambrou, Tryphon, Hutton, Brian F., Screaton, Nicholas J., Porter, Joanna C., Maher, Toby M., Endozo, Raymondo, Shortman, Robert I., Afaq, Asim, Lukey, Pauline, Ell, Peter J., Groves, Ashley M.
Foilsithe 2013

Pulmonary (18)F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)

le Win, Thida, Screaton, Nicholas J., Porter, Joanna C., Ganeshan, Balaji, Maher, Toby M., Fraioli, Francesco, Endozo, Raymondo, Shortman, Robert I., Hurrell, Lynn, Holman, Beverley F., Thielemans, Kris, Rashidnasab, Alaleh, Hutton, Brian F., Lukey, Pauline T., Flynn, Aiden, Ell, Peter J., Groves, Ashley M.
Foilsithe in Eur J Nucl Med Mol Imaging (2018)